Score all eight Revised Geneva criteria with point-by-point breakdown to classify PE pre-test probability as low, intermediate, or high.
Clinical Criteria
Check all criteria present in the patient. Points are summed automatically.
Heart Rate — select one if applicable
Revised Geneva Score
0
out of 22 possible points
Pre-Test Probability
—
Recommended Next Step
Score Breakdown
No criteria selected.
Summary
Score all eight Revised Geneva criteria with point-by-point breakdown to classify PE pre-test probability as low, intermediate, or high.
How it works
Read the clinical definition shown beneath each of the eight criteria.
Check every criterion that is present in the patient being evaluated.
Points are summed automatically; the running total appears in the score panel.
The risk tier (Low / Intermediate / High) updates in real time based on the total.
Review the recommended next diagnostic step shown under the risk badge.
Click Reset to clear all checkboxes and start a new evaluation.
Use cases
Stratify PE pre-test probability in the emergency department or inpatient ward.
Decide whether D-dimer testing alone can rule out PE without imaging.
Apply a fully objective scoring system when clinical gestalt is uncertain.
Teach Geneva criteria point values to medical students and residents.
Document objective risk stratification in clinical notes.
Cross-check bedside impression against a validated scoring rubric.
Compare Geneva and Wells scores for institutional standardization decisions.
Use alongside PERC rule for low-risk PE rule-out workflows.
Frequently Asked Questions
Eight objective criteria are scored: age >65 (1 pt), prior DVT or PE (3 pts), surgery/lower-limb fracture within 1 month (2 pts), active cancer (2 pts), unilateral lower-limb pain (3 pts), hemoptysis (2 pts), heart rate 75–94 bpm (3 pts) or ≥95 bpm (5 pts), and pain on deep palpation/unilateral edema (4 pts). Points are summed for a total score.
A score of 0–3 is Low probability (roughly 8% PE prevalence in validation studies). A score of 4–10 is Intermediate probability (roughly 29% prevalence). A score of 11 or above is High probability (roughly 74% prevalence). These thresholds are from the Klok et al. 2008 simplified version — many institutions use slight variations.
A low Geneva Score (0–3) combined with a negative D-dimer test has high negative predictive value and can safely exclude PE in most non-pregnant adult patients. A high-sensitivity D-dimer assay (≥95% sensitivity) is required. Clinical judgment must always be applied.
Heart rate 75–94 bpm earns 3 points; heart rate ≥95 bpm earns 5 points. These are mutually exclusive — select only one based on the observed heart rate. A heart rate below 75 bpm scores 0 points.
The original 2001 Geneva score included blood gas measurements (PaO2, PaCO2) and an x-ray finding, making it less practical at the bedside. The 2006 Revised Geneva Score removed those items and is entirely based on clinical history and physical examination, making it more practical.
Both estimate PE pre-test probability with similar diagnostic accuracy. The Revised Geneva Score is fully objective; the Wells score includes one clinical gestalt item ("PE is the most likely diagnosis"). Many clinicians use whichever their institution standardizes on. The YEARS algorithm and PERC rule are complementary tools for specific scenarios.
The Revised Geneva Score was not validated in pregnant patients. Suspected PE in pregnancy requires specialist guidance, modified imaging workup, and pregnancy-specific D-dimer thresholds. Do not apply this score alone to pregnant patients.
No. This tool is intended for educational and clinical decision-support purposes only. All diagnostic and treatment decisions must be made by a licensed clinician with full knowledge of the patient's history, examination, and test results.
